tirzepatide for cardiovascular disease effects of How the weight loss drug
Description
The broader point Lilly actually stumbles into is worth acknowledging
Keywords: Basal insulin, GLP-1 receptor agonists, Glycaemic control, Network meta-analysis, Tirzepatide, Type 2 diabetes mellitus Key Summary Points Introduction Type 2 diabetes mellitus (T2DM) is a progressive metabolic disease characterised by chronic hyperglycaemia [1]
Key Takeaways of the Global Tirzepatide Market Type 2 diabetes holds the largest market share by indication, accounting for an expected in 2026, due to the growing global prevalence of type 2 diabetes
Assuming it takes one month to enroll 50 patients, reducing the control arm by 330 patients could shorten enrollment timelines by six or more months, helping to determine the effects of a treatment sooner
Customer support can be slow
